Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning.
about
Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning.External assessment of the Early Mortality Risk Score in patients with adenocarcinoma undergoing pancreaticoduodenectomy.Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies.Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancerStereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.Dramatic Survival Benefit Related to R0 Resection of Pancreatic Adenocarcinoma in Patients With Tumor ≤25 mm in Size and ≤1 Involved Lymph NodesConformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study.The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma.Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design.Resectable, borderline resectable, and locally advanced pancreatic cancer: what does it matter?Dual-energy CT of pancreatic adenocarcinoma: reproducibility of primary tumor measurements and assessment of tumor conspicuity and margin sharpness.Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer.The borderline resectable/locally advanced pancreatic ductal adenocarcinoma: EUS oriented.
P2860
Q34013772-EEBC10FD-9517-41D7-B487-C660137FCB59Q35761105-70617C3F-898D-4A1F-ABCC-74F914CFA862Q35787410-8FFFAB53-DFA6-4E24-A83C-65234622E8EDQ36580127-E03D39E5-5EE0-40AB-9CDE-E3E03524B03DQ36715792-B80AB95A-FC13-4ADA-8707-95328CD2DD92Q36737989-3C9BB795-2A87-45C2-9197-AB28312179DDQ37401414-75E52DF2-1877-4262-B122-E7CEC54CABDDQ37721562-844BED65-1E2C-4DAF-B07C-4E01397AEA5EQ37723257-B2A7FC0D-F1B6-47DF-91CF-DDACB21EC38AQ38084124-0B0E4215-FBE3-4492-9E6B-EF8A8AE90E17Q38180310-9084D9D1-2D44-4398-94FB-7C45CBDCC777Q38766129-A585964B-DF2D-4F41-ACBE-5B09D3578D64Q44650366-49B6BFC9-E116-4791-A54A-5CF7A1ADDF01Q49507798-3897A982-F97C-4ED0-ABFF-A32B17D5C550
P2860
Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pancreatic cancer tumor size o ...... radiation treatment planning.
@en
Pancreatic cancer tumor size o ...... radiation treatment planning.
@nl
type
label
Pancreatic cancer tumor size o ...... radiation treatment planning.
@en
Pancreatic cancer tumor size o ...... radiation treatment planning.
@nl
prefLabel
Pancreatic cancer tumor size o ...... radiation treatment planning.
@en
Pancreatic cancer tumor size o ...... radiation treatment planning.
@nl
P2093
P2860
P1476
Pancreatic cancer tumor size o ...... radiation treatment planning.
@en
P2093
Andrzej Niemierko
Harvey J Mamon
Nils D Arvold
Theodore S Hong
P2860
P304
P356
10.1016/J.IJROBP.2010.04.058
P407
P577
2010-08-12T00:00:00Z